111 related articles for article (PubMed ID: 1932215)
1. Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC.
Linder KE; Wen MD; Nowotnik DP; Malley MF; Gougoutas JZ; Nunn AD; Eckelman WC
Bioconjug Chem; 1991; 2(3):160-70. PubMed ID: 1932215
[TBL] [Abstract][Full Text] [Related]
2. Technetium labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2.
Linder KE; Wen MD; Nowotnik DP; Ramalingam K; Sharkey RM; Yost F; Narra RK; Nunn AD; Eckelman WC
Bioconjug Chem; 1991; 2(6):407-14. PubMed ID: 1805937
[TBL] [Abstract][Full Text] [Related]
3. Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: syntheses and studies of their binding to the muscarinic acetylcholine receptor.
Jurisson SS; Pirro J; DiRocco RJ; Rosenspire KC; Jagoda E; Nanjappan P; Eckelman WC; Nowotnik DP; Nunn AD
Nucl Med Biol; 1995 Apr; 22(3):269-81. PubMed ID: 7627141
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and in vitro evaluation of nitroimidazole--BATO complexes: new technetium compounds designed for imaging hypoxic tissue.
Linder KE; Chan YW; Cyr JE; Nowotnik DP; Eckelman WC; Nunn AD
Bioconjug Chem; 1993; 4(5):326-33. PubMed ID: 8274515
[TBL] [Abstract][Full Text] [Related]
5. BATO complexes derived from dimethoxy dioximes: synthesis, characterization and biodistribution.
Ramalingam K; Jurisson SS; Kuczynski BL; Di Rocco R; Narra RK; Nowotnik DP; Nunn AD
Nucl Med Biol; 1995 Jul; 22(5):625-34. PubMed ID: 7581173
[TBL] [Abstract][Full Text] [Related]
6. Chloro----hydroxy substitution on technetium BATO [TcCl(dioxime)3 BR] complexes.
Jurisson SS; Hirth W; Linder KE; Di Rocco RJ; Narra RK; Nowotnik DP; Nunn AD
Int J Rad Appl Instrum B; 1991; 18(7):735-44. PubMed ID: 1787082
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and biological evaluation of cationic 99Tc/99mTc-dioxime complexes.
Schwochau K; Linse KH; Steinmetz HJ; Astheimer L
Nucl Med Biol; 1993 Apr; 20(3):317-24. PubMed ID: 8485491
[TBL] [Abstract][Full Text] [Related]
8. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
9. A new method of technetium-99m labeling of monoclonal antibodies through sugar residues. A study with TAG-72 specific CC-49 antibody.
Ranadive GN; Rosenzweig HS; Epperly MW; Seskey T; Bloomer WD
Nucl Med Biol; 1993 Aug; 20(6):719-26. PubMed ID: 8401372
[TBL] [Abstract][Full Text] [Related]
10.
Liu M; Liu S
Dalton Trans; 2017 Oct; 46(42):14509-14518. PubMed ID: 29087405
[TBL] [Abstract][Full Text] [Related]
11. Novel Approach for
Liu M; Zhao ZQ; Fang W; Liu S
Bioconjug Chem; 2017 Dec; 28(12):2998-3006. PubMed ID: 29148726
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells.
Kronauge JF; Chiu ML; Cone JS; Davison A; Holman BL; Jones AG; Piwnica-Worms D
Int J Rad Appl Instrum B; 1992 Feb; 19(2):141-8. PubMed ID: 1601667
[TBL] [Abstract][Full Text] [Related]
13. Impact of boronate capping groups on biological characteristics of novel (99m)Tc(III) complexes [(99m)TcCl(CDO)(CDOH)2B-R] (CDOH2 = cyclohexanedione dioxime).
Yang Y; Zheng Y; Tomaselli E; Fang W; Liu S
Bioconjug Chem; 2015 Feb; 26(2):316-28. PubMed ID: 25585053
[TBL] [Abstract][Full Text] [Related]
14. Novel biscapped and monocapped tris(dioxime) Mn(II) complexes: x-ray crystal structure of the first cationic tris(dioxime) Mn(II) complex [Mn(CDOH)3BPh]OH (CDOH2= 1,2-cyclohexanedione dioxime).
Hsieh WY; Liu S
Inorg Chem; 2006 Jun; 45(13):5034-43. PubMed ID: 16780325
[TBL] [Abstract][Full Text] [Related]
15. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
16. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.
Mastrostamatis SG; Papadopoulos MS; Pirmettis IC; Paschali E; Varvarigou AD; Stassinopoulou CI; Raptopoulou CP; Terzis A; Chiotellis E
J Med Chem; 1994 Sep; 37(20):3212-8. PubMed ID: 7932548
[TBL] [Abstract][Full Text] [Related]
17. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
Garron JY; Moinereau M; Pasqualini R; Saccavini JC
Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
[TBL] [Abstract][Full Text] [Related]
18. Solid phase labeling of monoclonal antibodies with 99mTc using two bifunctional photocleavable reagents.
Ranadive GN; Bloomer WD
Nucl Med Biol; 1995 Jul; 22(5):607-12. PubMed ID: 7581170
[TBL] [Abstract][Full Text] [Related]
19. A neutral lipophilic technetium-99m complex for regional cerebral blood flow imaging.
Narra RK; Nunn AD; Kuczynski BL; DiRocco RJ; Feld T; Silva DA; Eckelman WC
J Nucl Med; 1990 Aug; 31(8):1370-7. PubMed ID: 2384806
[TBL] [Abstract][Full Text] [Related]
20. [99mTc] Teboroxime and [99mTc]Cl(DMG)3B2MP: binding characteristics andmetabolism of two [99mTc]BATOs in blood and tissues.
Rosenspire KC; Rumsey WL; Jurisson S; Hirth W; Narra RK
Nucl Med Biol; 1993 May; 20(4):395-400. PubMed ID: 8504281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
